期刊
ONCOIMMUNOLOGY
卷 6, 期 8, 页码 -出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/2162402X.2017.1338235
关键词
chordoma; brachyury; immunotherapy; immune checkpoint inhibitors; melanoma antigens; neoantigen; tumor vaccine
资金
- l'Association Marietta, le Fond Lionel Perrier, l'Association Frederic Fellay, Fond'action
- la Ligue genevoise contre le Cancer
Chordoma is a rare tumor of notochordal origin, currently principally treated by surgery and/or irradiation. Here, we describe the clinical outcome of 3 consecutive patients with metastatic and locally advanced chordoma, treated with different immunotherapeutic approaches. All patients presented fast growing tumors and failure of standard therapies. One was treated with a tumor-based vaccine, the 2 others with anti-PD1 antibodies, all with impressive clinical and radiological responses. We therefore propose that chordoma is an immunogenic tumor and thus that translational and clinical research is necessary to develop rationally designed immunotherapy approaches.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据